Profil

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Personál20192020202120222023
Koncoročný počet zamestnancov8 1009 12310 36811 85113 450
Staff turnover in EUR905 844869 0831 446 422958 445910 012
Turnover LabelEUREUREUREUREUR
Akcie denominované v EUR20192020202120222023
Akcie v obehu (v miliónoch)0,100,100,10108,370,10
Dividenda na akciu-----
Zisk z podielu bez emisie nových akcií18,4630,5271,9738,2234,77
Prehľad ziskov a strát v miliónoch EUR podľa IAS/IFRS20192020202120222023
Obrat7 863,48 497,116 071,712 172,913 117,2
Prevádzkový zisk (EBIT)2 294,83 608,68 755,44 439,83 523,8
Zisk pred zdanením (EBT)2 429,13 810,49 325,84 858,84 199,3
Annual net profit/ loss2 115,83 513,28 075,34 338,43 953,6
Súvaha v miliónoch EUR IAS/IFRS20192020202120222023
Aktíva
Bežné aktíva celkom7 689,19 779,114 014,915 884,119 479,2
Celkové fixné aktíva7 116,17 384,211 419,913 388,613 651,4
Celkové aktíva14 805,217 163,325 434,829 272,733 130,6
Záväzky
Celkové krátkodobé záväzky2 096,62 697,43 932,53 141,33 423,4
Celkové dlhodobé záväzky1 618,93 440,62 733,53 467,43 734,1
Oprávky celkom0,00,00,00,00,0
Základný kapitál11 089,711 025,318 768,822 664,025 973,1
Celkové záväzky14 805,217 163,325 434,829 272,733 130,6
Management:
George Yancopoulos
Bonnie Bassler
Craig Thompson
David Schenkein
Huda Zoghbi
Joseph Goldstein
Kathryn Guarini
Michael Brown
N. Coles
Arthur Ryan
Christine Poon
George Sing
Leonard S. Schleifer
George D. Yancopoulos
Bob McCowan
Joseph J. LaRosa
Marion McCourt
Melissa Lozner
Robert E. Landry
Sally A. Paull
Smita Pillai
Predstavenstvo:
Štruktúra akcionárov v %:
BlackRock Fund Advisors 5,25
Capital Research & Management Co. (International Investors) 2,70
Capital Research & Management Co. (World Investors) 4,75
Dodge & Cox 2,19
Fidelity Management & Research Co. LLC 8,95
Geode Capital Management LLC 2,18
George Damis Yancopoulos 1,17
JPMorgan Investment Management, Inc. 5,11
SSgA Funds Management, Inc. 4,54
The Vanguard Group, Inc. 7,77
Streubesitz 55,37
Adresa: 777 Old Saw Mill River Road, 10591-6707 Tarrytown
T: +1-914-847-7000
F: +
I: http://www.regeneron.com
E: usinfo@regeneron.com